Ana Rozas-Carrasco
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy.
Journal: Frontiers in cell and developmental biology
Published: October 03, 2024
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients.
Journal: The American journal of pathology
Published: February 07, 2022
RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: May 19, 2021
Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies.
Journal: Frontiers in neurology
Published: February 02, 2021
Downregulation of miR-335-5P in Amyotrophic Lateral Sclerosis Can Contribute to Neuronal Mitochondrial Dysfunction and Apoptosis.
Journal: Scientific reports
Published: October 14, 2019
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 18, 2019
Identification of serum microRNAs as potential biomarkers in Pompe disease.
Journal: Annals of clinical and translational neurology
Published: March 14, 2019
Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT.
Journal: Molecular genetics and metabolism
Published: December 20, 2018
PDGF-BB serum levels are decreased in adult onset Pompe patients.
Journal: Scientific reports
Published: July 24, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026